Stoma

Virtual Second Opinions Save Over $8,700 Per Patient, New Analysis Finds

Retrieved on: 
Tuesday, March 26, 2024

A new quantitative case analysis from The Clinic by Cleveland Clinic , a leading provider of virtual second opinions (VSOs), reveals that its second opinions produce an average savings of $8,705 per patient.

Key Points: 
  • A new quantitative case analysis from The Clinic by Cleveland Clinic , a leading provider of virtual second opinions (VSOs), reveals that its second opinions produce an average savings of $8,705 per patient.
  • The analysis of The Clinic’s VSOs demonstrates that second opinions from expert specialists can prevent misdiagnoses and overtreatment.
  • Key findings from the analysis include:
    In addition to savings, the analysis uncovered numerous examples of the dramatic impact of VSOs on patients’ peace of mind and quality of life.
  • Even if major surgery is indeed right for you, a virtual second opinion provides confidence that you’re on the right path.

Printed Electronics Converge: 3 Key Insights from IDTechEx at LOPEC 2024

Retrieved on: 
Wednesday, March 20, 2024

BOSTON, March 20, 2024 /PRNewswire/ -- In March, the printed electronics industry flocked to Munich once again for the LOPEC 2024 conference and exhibition.

Key Points: 
  • BOSTON, March 20, 2024 /PRNewswire/ -- In March, the printed electronics industry flocked to Munich once again for the LOPEC 2024 conference and exhibition.
  • Printed electronics technology providers were, as usual, out in force to demonstrate their suitability to meet these challenges.
  • Leveraging established partnerships to build confidence and nurture interest from manufacturers was the focus of printed electronics technology companies at LOPEC 2024.
  • For more analysis on printed electronics technology, markets, and forecasts, see IDTechEx's dedicated reports on Printed and Flexible Sensors , Conductive Inks , and 3D Electronics .

Printed Electronics Converge: 3 Key Insights from IDTechEx at LOPEC 2024

Retrieved on: 
Wednesday, March 20, 2024

BOSTON, March 20, 2024 /PRNewswire/ -- In March, the printed electronics industry flocked to Munich once again for the LOPEC 2024 conference and exhibition.

Key Points: 
  • BOSTON, March 20, 2024 /PRNewswire/ -- In March, the printed electronics industry flocked to Munich once again for the LOPEC 2024 conference and exhibition.
  • Printed electronics technology providers were, as usual, out in force to demonstrate their suitability to meet these challenges.
  • Leveraging established partnerships to build confidence and nurture interest from manufacturers was the focus of printed electronics technology companies at LOPEC 2024.
  • For more analysis on printed electronics technology, markets, and forecasts, see IDTechEx's dedicated reports on Printed and Flexible Sensors , Conductive Inks , and 3D Electronics .

Edgepark adding first-of-its kind, fully automated insulin delivery system to diabetes portfolio

Retrieved on: 
Tuesday, February 13, 2024

TWINSBURG, Ohio, Feb. 13, 2024 /PRNewswire/ -- Edgepark announced today it is offering the newly launched Beta Bionics iLet Bionic Pancreas fully automated insulin delivery (AID) system as part of its comprehensive diabetes management solution portfolio. The iLet is the first and only system that does not require carbohydrate counting* and fully automates 100 percent of insulin doses. Designed for anyone six years of age and older living with Type 1 diabetes, it eliminates the traditional manual work previously involved with using an insulin pump.

Key Points: 
  • TWINSBURG, Ohio, Feb. 13, 2024 /PRNewswire/ -- Edgepark announced today it is offering the newly launched Beta Bionics iLet Bionic Pancreas fully automated insulin delivery (AID) system as part of its comprehensive diabetes management solution portfolio.
  • The iLet is the first and only system that does not require carbohydrate counting* and fully automates 100 percent of insulin doses.
  • "Edgepark is thrilled to offer the iLet as a first-of-its-kind device that uses automation to make diabetes simpler to navigate."
  • As with any insulin delivery system, users must also be able to load the insulin pump with insulin, insert an infusion set and troubleshoot when challenges occur.

Why are manufacturing companies moving to the Dominican Republic?

Retrieved on: 
Wednesday, December 20, 2023

SANTO DOMINGO, Dominican Republic, Dec. 20, 2023 (GLOBE NEWSWIRE) -- In a bold strategy that has revolutionized the international investment landscape, a growing number of free zone companies are making the Dominican Republic their top choice, relocating their businesses, as well as their production plants.

Key Points: 
  • SANTO DOMINGO, Dominican Republic, Dec. 20, 2023 (GLOBE NEWSWIRE) -- In a bold strategy that has revolutionized the international investment landscape, a growing number of free zone companies are making the Dominican Republic their top choice, relocating their businesses, as well as their production plants.
  • This robust tax exemption framework, under Law 8-90, grants complete exemptions, amounting to 100% for nearly all national and local taxes.
  • Companies enjoy no logistical complications thanks to the proximity to key markets in the United States and Europe.
  • The Dominican Republic's nearshoring success stories span across various industries, with several multinational companies choosing to move their operations to the country.

Savage Medical Exits Stealth With Over $3 Million to Enable Minimally Invasive Colorectal Tumor Removal

Retrieved on: 
Tuesday, November 28, 2023

Capital raised contributes to SavageMed's ongoing clinical trial of its groundbreaking ColoSeal™ System.

Key Points: 
  • Capital raised contributes to SavageMed's ongoing clinical trial of its groundbreaking ColoSeal™ System.
  • "ColoSeal allows a one-time, minimally invasive procedure after the tumor removal that potentially eliminates the need for the additional surgical procedures and avoids need for an ostomy."
  • "Every year, there are 1.9 million people diagnosed with colorectal cancer.
  • Our vision is to replace the multiple surgical procedures and complications that hundreds of thousands of colorectal patients endure each year with a minimally invasive solution."

Henry Schein Completes Acquisition of a Majority Interest in Shield Healthcare, Inc.

Retrieved on: 
Wednesday, October 18, 2023

Henry Schein announced the agreement to acquire Shield Healthcare on August 3, 2023.

Key Points: 
  • Henry Schein announced the agreement to acquire Shield Healthcare on August 3, 2023.
  • Henry Schein expects the transaction to be neutral to 2023 non-GAAP earnings per share and accretive thereafter.
  • “Through our strategic homecare products investments, our Henry Schein Medical business is increasingly well positioned to compete in the homecare medical supplies market.
  • The current owners of Shield Healthcare, including members of the company’s management team, will retain a minority ownership position in the company.

Oncotech AI-powered diagnostic mobile cancer and diabetes screening app Ophtascan™ gains distribution with Medical Express Romania

Retrieved on: 
Tuesday, October 10, 2023

LONDON, Oct. 10, 2023 /PRNewswire/ -- Medical technology innovator Oncotech Nordic AB, awarded CE marking in 2022 for its mobile cancer and diabetes type 2 health screening app, Ophtascan™, is being launched in Romania for the first time this autumn through a new partnership with Medical Express Romania.

Key Points: 
  • LONDON, Oct. 10, 2023 /PRNewswire/ -- Medical technology innovator Oncotech Nordic AB, awarded CE marking in 2022 for its mobile cancer and diabetes type 2 health screening app, Ophtascan™, is being launched in Romania for the first time this autumn through a new partnership with Medical Express Romania.
  • The mobile screening app is already being trialled and launched by doctors and patients in Central Africa, where there is huge demand for cancer and diabetes type 2 screening and diagnostics.
  • Using the app, physicians can use their own smartphone devices to photograph the iris of their patients and upload images to the Oncotech server.
  • The Oncotech AI diagnostic and machine learning system then sends the results back to the clinician within just 45 seconds.

Oncotech AI-powered diagnostic mobile cancer and diabetes screening app Ophtascan™ gains distribution with Medical Express Romania

Retrieved on: 
Tuesday, October 10, 2023

LONDON, Oct. 10, 2023 /PRNewswire/ -- Medical technology innovator Oncotech Nordic AB, awarded CE marking in 2022 for its mobile cancer and diabetes type 2 health screening app, Ophtascan™, is being launched in Romania for the first time this autumn through a new partnership with Medical Express Romania.

Key Points: 
  • LONDON, Oct. 10, 2023 /PRNewswire/ -- Medical technology innovator Oncotech Nordic AB, awarded CE marking in 2022 for its mobile cancer and diabetes type 2 health screening app, Ophtascan™, is being launched in Romania for the first time this autumn through a new partnership with Medical Express Romania.
  • The mobile screening app is already being trialled and launched by doctors and patients in Central Africa, where there is huge demand for cancer and diabetes type 2 screening and diagnostics.
  • Using the app, physicians can use their own smartphone devices to photograph the iris of their patients and upload images to the Oncotech server.
  • The Oncotech AI diagnostic and machine learning system then sends the results back to the clinician within just 45 seconds.

InventHelp Inventor Develops New Ostomy Punch Tool (CHK-977)

Retrieved on: 
Friday, September 8, 2023

PITTSBURGH, Sept. 8, 2023 /PRNewswire/ -- "My wife has an ostomy and I thought there could be a better way to cut the hole in the skin barrier that attaches to the ostomy bag," said an inventor, from Crown Point, Ind., "so I invented the OSTOMY PUNCH.

Key Points: 
  • PITTSBURGH, Sept. 8, 2023 /PRNewswire/ -- "My wife has an ostomy and I thought there could be a better way to cut the hole in the skin barrier that attaches to the ostomy bag," said an inventor, from Crown Point, Ind., "so I invented the OSTOMY PUNCH.
  • The patent-pending invention provides an effective way to ensure a custom fit of an ostomy skin barrier.
  • In doing so, it ensures that the ostomy bag remains securely in place around the stoma.
  • The invention features a customizable and adjustable design that is easy to use so it is ideal for ostomy users.